Crescent Pharma Limted
• Crescent Pharma Limited scheduled a meeting with the MHRA in January 2015 to discuss packaging redesign and the use of colour to differentiate products. • The company stated that agreement on design and a product range colour chart would lead to the creation of new artwork for all its products. • This new artwork would be submitted for MHRA approval, with its introduction coordinated following approval.
View full response
2014. Agreement of design and product range colour chart will lead to the creation of new artwork for all Crescent products, submission for MHRA approval and co-ordination of new artwork introduction after MHRA approval. We are unable to provide a timeline for project completion currently: Crescent are therefore committed to revising product artwork to help minimise pharmacist error, caused by the failure to verify product identity during dispensing: this answers the request to provide a response to the report provided.